FDA to launch advisory committee on digital health technologies
The Food and Drug Administration will accept nominations through Dec. 11 for experts to serve on a committee that will advise the agency on issues related to digital health technologies, from artificial intelligence/machine learning and digital therapeutics to wearables and remote patient monitoring.
“Many of these technologies are novel and tend to rapidly change; it’s our duty to seek as much knowledge on them as possible as we determine and implement appropriate regulation to encourage innovation while protecting public health,” said Troy Tazbaz, director of the FDA’s Digital Health Center of Excellence.
Related News Articles
Headline
The National Security Agency April 23 released a report on operational technology systems that includes recommendations for security policies and technical…
Chairperson's File
Cybersecurity and physical threats are unfortunately significant enterprise risks for health care, regardless of size or location. Every hospital, physician…
Headline
The Cybersecurity and Infrastructure Security Agency April 17 released guidance to reduce risks associated with a reported breach of Oracle cloud services.…
Headline
The National Counterintelligence and Security Center, the FBI, and the Defense Counterintelligence and Security Center yesterday released guidance on…
AHA Cyber Intel
While the rate of cyberattacks on hospitals has risen dramatically, the severity of the impacts has also grown exponentially. Let’s look at the state of cyber…
Headline
The House Energy and Commerce Oversight and Investigations Subcommittee April 1 discussed cybersecurity threats in legacy medical devices during a hearing. The…